Table 1.
Characteristics of 62 533 high‐risk prostate cancer patients
| EBRT | EBRT + BT | Surgery | |
|---|---|---|---|
| Patients, n | 2638 | 355 | 59 540 |
| Mean age (years) | 69.4 | 66.1 | 63.8 |
| Age group, n (%) | |||
| <50 | 27 (1.0) | 6 (1.7) | 2038 (3.4) |
| 50‐65 | 818 (31.0) | 165 (46.5) | 33 343 (56.0) |
| 66‐75 | 1151 (43.6) | 139 (39.2) | 19 507 (32.8) |
| >75 | 642 (24.3) | 45 (12.7) | 4652 (7.8) |
| Ethnicity, n (%) | |||
| White | 1809 (68.6) | 259 (73.0) | 47 699 (80.1) |
| Black | 638 (24.2) | 71 (20.0) | 7663 (12.9) |
| Other | 133 (5.0) | 22 (6.2) | 3675 (6.2) |
| Unknown | 58 (2.2) | 3 (0.8) | 503 (0.8) |
| Tumor grade, n (%) | |||
| Grade I | 19 (0.7) | 1 (0.3) | 466 (0.8) |
| Grade II | 268 (10.2) | 34 (9.6) | 10 827 (18.2) |
| Grade III/IV | 2351 (89.1) | 320 (90.1) | 48 247 (81.0) |
| T stage, n (%) | |||
| T1 | 1287 (48.8) | 162 (45.6) | 3730 (6.3) |
| T2 | 1071 (40.6) | 151 (42.5) | 15 041 (25.3) |
| T3 | 259 (9.8) | 41 (11.5) | 37 210 (62.5) |
| T4 | 21 (0.8) | 1 (0.3) | 3559 (6.0) |
| Location, n (%) | |||
| East | 932 (35.3) | 61 (17.2) | 9353 (15.7) |
| West | 675 (25.6) | 93 (26.2) | 29 070 (48.8) |
| Midwest | 499 (18.9) | 115 (32.4) | 6466 (10.9) |
| South | 214 (8.1) | 60 (16.9) | 12 098 (20.3) |
| Southwest | 266 (10.1) | 7 (2.0) | 1316 (2.2) |
| Others | 52 (2.0) | 19 (5.4) | 1237 (2.1) |
| PSA (ng/dl), n (%) | |||
| <10 | 1166 (44.2) | 177 (49.9) | 38 312 (64.3) |
| 10‐20 | 487 (18.5) | 64 (18.0) | 10 622 (17.8) |
| >20 | 985 (37.3) | 114 (32.1) | 10 606 (17.8) |
| Gleason score, n (%) | |||
| ≤6 | 173 (6.6) | 27 (7.6) | 7874 (13.2) |
| 7 | 477 (18.1) | 63 (17.7) | 25 834 (43.4) |
| 8‐10 | 1976 (74.9) | 265 (74.6) | 25 616 (43.0) |
| Unknown | 12 (0.5) | 0 (0.0) | 216 (0.4) |
| Marital status, n (%) | |||
| No partner | 476 (18.0) | 52 (14.6) | 6374 (10.7) |
| With partner | 1435 (54.4) | 221 (62.3) | 43 933 (73.8) |
| Single | 297 (11.3) | 28 (7.9) | 5945 (10.0) |
| Unknown | 430 (16.3) | 54 (15.2) | 3288 (5.5) |